Kelly Lechtenberg

1.8k total citations
67 papers, 1.3k citations indexed

About

Kelly Lechtenberg is a scholar working on Microbiology, Infectious Diseases and Small Animals. According to data from OpenAlex, Kelly Lechtenberg has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Microbiology, 20 papers in Infectious Diseases and 19 papers in Small Animals. Recurrent topics in Kelly Lechtenberg's work include Microbial infections and disease research (24 papers), Animal Disease Management and Epidemiology (11 papers) and Streptococcal Infections and Treatments (8 papers). Kelly Lechtenberg is often cited by papers focused on Microbial infections and disease research (24 papers), Animal Disease Management and Epidemiology (11 papers) and Streptococcal Infections and Treatments (8 papers). Kelly Lechtenberg collaborates with scholars based in United States, United Kingdom and United Arab Emirates. Kelly Lechtenberg's co-authors include T. G. Nagaraja, T. G. Nagaraja, M. M. Chengappa, Heinz Leipold, Jan M. Sargeant, David G. Renter, Daniel U. Thomson, Charley A. Cull, Brad M. DeBey and David P. Gnad and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied and Environmental Microbiology and Annals of Surgery.

In The Last Decade

Kelly Lechtenberg

65 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly Lechtenberg United States 19 458 452 275 257 247 67 1.3k
Andrea Luppi Italy 19 204 0.4× 358 0.8× 261 0.9× 295 1.1× 326 1.3× 67 1.6k
Bo Norby United States 28 774 1.7× 381 0.8× 401 1.5× 171 0.7× 160 0.6× 90 2.1k
Paula Menzies Canada 24 451 1.0× 307 0.7× 759 2.8× 260 1.0× 196 0.8× 87 1.7k
Serge Messier Canada 27 294 0.6× 433 1.0× 216 0.8× 213 0.8× 170 0.7× 66 1.6k
Joyce Van Donkersgoed Canada 21 296 0.6× 384 0.8× 191 0.7× 165 0.6× 336 1.4× 59 1.2k
Claire Stein United States 5 255 0.6× 478 1.1× 339 1.2× 558 2.2× 78 0.3× 11 1.5k
Daniel U. Thomson United States 23 521 1.1× 359 0.8× 618 2.2× 571 2.2× 212 0.9× 112 1.6k
R. Miserez Switzerland 18 288 0.6× 416 0.9× 236 0.9× 106 0.4× 61 0.2× 35 1.3k
Frédéric Vangroenweghe Belgium 23 640 1.4× 166 0.4× 301 1.1× 310 1.2× 177 0.7× 52 1.4k
Jerome C. Nietfeld United States 24 261 0.6× 592 1.3× 168 0.6× 579 2.3× 75 0.3× 71 1.5k

Countries citing papers authored by Kelly Lechtenberg

Since Specialization
Citations

This map shows the geographic impact of Kelly Lechtenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Lechtenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Lechtenberg more than expected).

Fields of papers citing papers by Kelly Lechtenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Lechtenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Lechtenberg. The network helps show where Kelly Lechtenberg may publish in the future.

Co-authorship network of co-authors of Kelly Lechtenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Lechtenberg. A scholar is included among the top collaborators of Kelly Lechtenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Lechtenberg. Kelly Lechtenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yuan, Fangfeng, Chi Chen, Victor C. Huber, et al.. (2023). Establish a Pregnant Sow–Neonate Model to Assess Maternal Immunity of a Candidate Influenza Vaccine. Vaccines. 11(3). 646–646. 4 indexed citations
3.
Kleinhenz, Michael D., Abbie V. Viscardi, Shawnee Montgomery, et al.. (2022). Comparison of lidocaine alone or in combination with a local nerve block of ethanol, bupivacaine liposome suspension, or oral meloxicam to extend analgesia after scoop dehorning in Holstein calves. SHILAP Revista de lepidopterología. 3(3). 189–194. 2 indexed citations
4.
Cull, Charley A., et al.. (2022). Comparison of two distinct arrival and treatment programs for bovine respiratory disease in high-risk feeder cattle entering a feedlot. Translational Animal Science. 6(3). txac102–txac102. 1 indexed citations
5.
Viscardi, Abbie V., Charley A. Cull, Michael D. Kleinhenz, et al.. (2020). Using a CO2 Surgical Laser for Piglet Castration to Reduce Pain and Inflammation, and to Improve Wound Healing. Kansas Agricultural Experiment Station Research Reports. 6(10). 1 indexed citations
7.
Lechtenberg, Kelly. (2019). Bovine respiratory disease modeling. American Association of Bovine Practitioners Conference Proceedings. 89–92. 1 indexed citations
8.
Nickell, Jason S., et al.. (2016). Efficacy and safety of a novel DNA immunostimulant in cattle. The Bovine Practitioner. 9–20. 13 indexed citations
9.
Lechtenberg, Kelly, et al.. (2011). Field Efficacy Study of Gamithromycin for the Control of Bovine Respiratory Disease in Cattle at High Risk of Developing the Disease. 9(2). 184–192. 15 indexed citations
10.
Thomson, Daniel U., et al.. (2009). Use of a Siderophore Receptor and Porin Proteins-Based Vaccine to Control the Burden of Escherichia coli O157:H7 in Feedlot Cattle. Foodborne Pathogens and Disease. 6(7). 871–877. 57 indexed citations
11.
Skogerboe, T. L., et al.. (2005). Comparative efficacy of tulathromycin, tilmicosin, and florfenicol in the treatment of bovine respiratory disease in stocker cattle.. PubMed. 6(2). 167–79. 17 indexed citations
12.
Lechtenberg, Kelly, et al.. (2003). Efficacy of ceftiofur sodium for the control of mortality in neonatal pigs orally inoculated with K88+ (F4+) enterotoxigenic Escherichia coli. Journal of Swine Health and Production. 11(1). 7–11. 1 indexed citations
13.
Hamm, Michael, Terry N. TerHune, Kelly Lechtenberg, et al.. (1999). Clinical efficacy of enrofloxacin against bovine respiratory disease comparing different treatment regimens. The Bovine Practitioner. 56–59. 9 indexed citations
14.
Fajt, Virginia R. & Kelly Lechtenberg. (1998). Using anti-inflammatories in the treatment of bovine respiratory disease. 19(6). 34–39. 5 indexed citations
15.
Parrott, J C, et al.. (1998). Effect of monensin, laidomycin, and lasalocid on coccidiosis control weight gain and feed intake in young calves. Journal of Dairy Science. 81(4). 1200–1200. 4 indexed citations
16.
Lechtenberg, Kelly, T. G. Nagaraja, & M. M. Chengappa. (1998). Antimicrobial susceptibility of Fusobacterium necrophorum isolated from bovine hepatic abscesses. American Journal of Veterinary Research. 59(1). 44–47. 23 indexed citations
17.
Kwang, Jimmy, et al.. (1997). Application of recombinant bovine viral diarrhea virus proteins in the diagnosis of bovine viral diarrhea infection in cattle. Veterinary Microbiology. 57(2-3). 119–133. 14 indexed citations
18.
Mowrey, Daniel H, et al.. (1996). Efficacy dose determination study of tilmicosin phosphate in feed for control of pneumonia caused by Actinobacillus pleuropneumoniae in swine. American Journal of Veterinary Research. 57(2). 220–223. 17 indexed citations
19.
Lechtenberg, Kelly & T. G. Nagaraja. (1991). Hepatic ultrasonography and blood changes in cattle with experimentally induced hepatic abscesses. American Journal of Veterinary Research. 52(6). 803–809. 44 indexed citations
20.
Lechtenberg, Kelly, T. G. Nagaraja, Heinz Leipold, & M. M. Chengappa. (1988). Bacteriologic and histologic studies of hepatic abscesses in cattle. American Journal of Veterinary Research. 49(1). 58–62. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026